Focused SOAP Note for Schizophrenia Spectrum, Other Psychotic, and Medication-Induced Movement Disorders

  

Assignment: Focused SOAP Note for

Schizophrenia

Spectrum, Other Psychotic, and Medication-Induced Movement Disorders

For this Assignment, you will complete a focused SOAP note for a patient in a case study who has either a schizophrenia spectrum, other psychotic, or medication-induced movement disorder. 

To Prepare

Review this

   

   week’s Learning Resources. Consider the insights they provide about       assessing, diagnosing, and treating schizophrenia spectrum, other       psychotic, and medication-induced movement disorders.

Review the      Focused SOAP Note template, which you will use to complete this      Assignment. There is also a Focused SOAP Note Exemplar provided as a guide      for Assignment expectations.

Review the      video, Case Study: Sherman Tremaine. You will use this case as      the basis of this Assignment. In this video, a Walden faculty member is      assessing a mock patient. The patient will be represented onscreen as an      avatar.

Consider what      history would be necessary to collect from this patient.

Consider what      interview questions you would need to ask this patient.

The Assignment

Develop a focused SOAP note, including your differential diagnosis and critical-thinking process to formulate a primary diagnosis. Incorporate the following into your responses in the template:

• Subjective: What details      did the patient provide regarding their chief complaint and symptomology      to derive your differential diagnosis? What is the duration and severity      of their symptoms? How are their symptoms impacting their functioning in      life? 
• Objective: What      observations did you make during the psychiatric assessment?  
• Assessment: Discuss      the patient’s mental status examination results. What were your      differential diagnoses? Provide a minimum of three possible diagnoses with      supporting evidence, and list them in order from highest priority to      lowest priority. Compare the DSM-5-TR diagnostic criteria      for each differential diagnosis and explain what DSM-5-TR criteria      rules out the differential diagnosis to find an accurate diagnosis.      Explain the critical-thinking process that led you to the primary      diagnosis you selected. Include pertinent positives and pertinent      negatives for the specific patient case.
• Plan: What is      your plan for psychotherapy? What is your plan for treatment and      management, including alternative therapies? Include pharmacologic and      nonpharmacologic treatments, alternative therapies, and follow-up      parameters, as well as a rationale for this treatment and management      plan. Also incorporate one health promotion activity and one patient      education strategy.
• Reflection      notes: What      would you do differently with this patient if you could conduct the      session again? Discuss what your next intervention would be if you      were able to follow up with this patient. Also include in your reflection      a discussion related to legal/ethical considerations (demonstrate critical      thinking beyond confidentiality and consent for treatment!), health      promotion, and disease prevention, taking into consideration patient factors      (such as age, ethnic group, etc.), PMH, and other risk factors (e.g.,      socioeconomic, cultural background, etc.).
• Provide at      least three evidence-based, peer-reviewed journal articles or      evidenced-based guidelines that relate to this case to support your      diagnostics and differential diagnoses. Be sure they are current (no more      than 5 years old).

Medication Review

Review the FDA-approved use of the following medicines related to treating schizophrenia-spectrum and other psychotic disorders:

   

Psychosis

Schizoaffective    disorder

 

alprazolam (adjunct)
  amisulpride
  aripiprazole
  asenapine
  blonanserin
  carbamazepine (adjunct)
  chlorpromazine
  clonazepam (adjunct)
  clozapine
  cyamemazine
  flupenthixol
  fluphenazine
  haloperidol
  iloperidone
  lamotrigine (adjunct)
  lorazepam (adjunct)
  loxapine
  lurasidone

mesoridazine
  molindone
  olanzapine
  paliperidone
  perospirone
  perphenazine
  pimozide
  pipothiazine
  quetiapine
  risperidone
  sertindole
  sulpiride
  thioridazine
  thiothixene
  trifluoperazine
  valproate (divalproex) (adjunct)
  ziprasidone
  zotepine
  zuclopenthixol

amisulpride
  aripiprazole
  asenapine
  carbamazepine (adjunct)
  chlorpromazine
  clozapine
  cyamemazine
  flupenthixol
  haloperidol
  iloperidone
  lamotrigine (adjunct)
  l-methylfolate (adjunct)
  loxapine
  lurasidone
  mesoridazine
  molindone
  olanzapine
  paliperidone

perospirone
  perphenazine
  pipothiazine
  quetiapine
  risperidone
  sertindole
  sulpiride
  thioridazine
  thiothixene
  trifluoperazine
  valproate (divalproex) (adjunct)
  ziprasidone
  zotepine
  zuclopenthixol

  
Schizophrenia

Cataplexy syndrome

Catatonia

Extrapyramidal side    effects

 

amisulpride
  aripiprazole
  asenapine
  carbamazepine (adjunct)
  chlorpromazine
  clozapine
  cyamemazine
  flupenthixol
  haloperidol
  iloperidone
  lamotrigine (adjunct)
  l-methylfolate (adjunct)
  loxapine
  lurasidone
  mesoridazine
  molindone
  olanzapine
  paliperidone
  perospirone

perphenazine
  pipothiazine
  quetiapine
  risperidone
  sertindole
  sulpiride
  thioridazine
  thiothixene
  trifluoperazine
  valproate (divalproex) (adjunct)
  ziprasidone
  zotepine
  zuclopenthixol
  Seasonal affective disorder
  bupropion
  Sedation-induction
  hydroxyzine
  midazolam

clomipramine
  imipramine
  sodiu

         

Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015). Kaplan & Sadock’s synopsis of psychiatry (11th ed.). Wolters Kluwer. (For review as needed)

• Chapter 7, “Schizophrenia      Spectrum and Other Psychotic Disorders”
• Chapter 29.2,      “Medication-Induced Movement Disorders”
• Chapter 29.3, “α2-Adrenergic      Receptor Agonists, α1-Adrenergic Receptor Antagonists:      Clonidine, Guanfacine, Prazosin, and Yohimbine”

Thapar, A., Pine, D. S., Leckman, J. F., Scott, S., Snowling, M. J., & Taylor, E. A. (Eds.). (2015). Rutter’s child and adolescent psychiatry (6th ed.). Wiley Blackwell.  

· Chapter 43, “Pharmacological, Medically-Led and Related Disorders”

· Chapter 57, “Schizophrenia and Psychosis”

Zakhari, R. (2021). The psychiatric-mental health nurse practitioner certification review manual. Springer Publishing Company. 

· Chapter 9, “Psychotic Disorders and Delusions”

REQUIRED MEDIA

Assignment: Focused SOAP Note for

Schizophrenia

Spectrum, Other Psychotic, and Medication-Induced Movement Disorders

For this Assignment, you will complete a focused SOAP note for a patient in a case study who has either a schizophrenia spectrum, other psychotic, or medication-induced movement disorder. 

To Prepare

· Review this week’s Learning Resources. Consider the insights they provide about assessing, diagnosing, and treating schizophrenia spectrum, other psychotic, and medication-induced movement disorders.

· Review the Focused SOAP Note template, which you will use to complete this Assignment. There is also a Focused SOAP Note Exemplar provided as a guide for Assignment expectations.

· Review the video, 
Case Study: Sherman Tremaine. You will use this case as the basis of this Assignment. In this video, a Walden faculty member is assessing a mock patient. The patient will be represented onscreen as an avatar.

· Consider what history would be necessary to collect from this patient.

· Consider what interview questions you would need to ask this patient.

The Assignment

Develop a focused SOAP note, including your differential diagnosis and critical-thinking process to formulate a primary diagnosis. Incorporate the following into your responses in the template:

·
Subjective: What details did the patient provide regarding their chief complaint and symptomology to derive your differential diagnosis? What is the duration and severity of their symptoms? How are their symptoms impacting their functioning in life? 

·
Objective: What observations did you make during the psychiatric assessment?  

·
Assessment: Discuss the patient’s mental status examination results. What were your differential diagnoses? Provide a minimum of three possible diagnoses with supporting evidence, and list them in order from highest priority to lowest priority. Compare the 
DSM-5-TR diagnostic criteria for each differential diagnosis and explain what 
DSM-5-TR criteria rules out the differential diagnosis to find an accurate diagnosis. Explain the critical-thinking process that led you to the primary diagnosis you selected. Include pertinent positives and pertinent negatives for the specific patient case.

·
Plan: What is your plan for psychotherapy? What is your plan for treatment and management, including alternative therapies? Include pharmacologic and nonpharmacologic treatments, alternative therapies, and follow-up parameters, as well as a rationale for this treatment and management plan. Also incorporate one health promotion activity and one patient education strategy.

·
Reflection notes: What would you do differently with this patient if you could conduct the session again? Discuss what your next intervention would be if you were able to follow up with this patient. Also include in your reflection a discussion related to legal/ethical considerations (demonstrate critical thinking beyond confidentiality and consent for treatment!), health promotion, and disease prevention, taking into consideration patient factors (such as age, ethnic group, etc.), PMH, and other risk factors (e.g., socioeconomic, cultural background, etc.).

· Provide at least three evidence-based, peer-reviewed journal articles or evidenced-based guidelines that relate to this case to support your diagnostics and differential diagnoses. Be sure they are current (no more than 5 years old).

Medication Review

Review the FDA-approved use of the following medicines related to treating schizophrenia-spectrum and other psychotic disorders:

Psychosis	Schizoaffective disorder
alprazolam (adjunct) amisulpride aripiprazole asenapine blonanserin carbamazepine (adjunct) chlorpromazine clonazepam (adjunct) clozapine cyamemazine flupenthixol fluphenazine haloperidol iloperidone lamotrigine (adjunct) lorazepam (adjunct) loxapine lurasidone	mesoridazine molindone olanzapine paliperidone perospirone perphenazine pimozide pipothiazine quetiapine risperidone sertindole sulpiride thioridazine thiothixene trifluoperazine valproate (divalproex) (adjunct) ziprasidone zotepine zuclopenthixol	amisulpride aripiprazole asenapine carbamazepine (adjunct) chlorpromazine clozapine cyamemazine flupenthixol haloperidol iloperidone lamotrigine (adjunct) l-methylfolate (adjunct) loxapine lurasidone mesoridazine molindone olanzapine paliperidone	perospirone perphenazine pipothiazine quetiapine risperidone sertindole sulpiride thioridazine thiothixene trifluoperazine valproate (divalproex) (adjunct) ziprasidone zotepine zuclopenthixol
Schizophrenia	Cataplexy syndrome	Catatonia	Extrapyramidal side effects
amisulpride aripiprazole asenapine carbamazepine (adjunct) chlorpromazine clozapine cyamemazine flupenthixol haloperidol iloperidone lamotrigine (adjunct) l-methylfolate (adjunct) loxapine lurasidone mesoridazine molindone olanzapine paliperidone perospirone	perphenazine pipothiazine quetiapine risperidone sertindole sulpiride thioridazine thiothixene trifluoperazine valproate (divalproex) (adjunct) ziprasidone zotepine zuclopenthixol Seasonal affective disorder bupropion Sedation-induction hydroxyzine midazolam	clomipramine imipramine sodiu

Sadock, B. J., Sadock, V. A., & Ruiz, P. (2015).
Kaplan & Sadock’s synopsis of psychiatry (11th ed.). Wolters Kluwer. (For review as needed)

· Chapter 7, “Schizophrenia Spectrum and Other Psychotic Disorders”

· Chapter 29.2, “Medication-Induced Movement Disorders”

· Chapter 29.3, “α2-Adrenergic Receptor Agonists, α1-Adrenergic Receptor Antagonists: Clonidine, Guanfacine, Prazosin, and Yohimbine”

Thapar, A., Pine, D. S., Leckman, J. F., Scott, S., Snowling, M. J., & Taylor, E. A. (Eds.). (2015).
Rutter’s child and adolescent psychiatry (6th ed.). Wiley Blackwell.  

· Chapter 43, “Pharmacological, Medically-Led and Related Disorders”

· Chapter 57, “Schizophrenia and Psychosis”

Zakhari, R. (2021).
The psychiatric-mental health nurse practitioner certification review manual. Springer Publishing Company.

· Chapter 9, “Psychotic Disorders and Delusions”

REQUIRED MEDIA

Walden University. (2021).
Case study: Sherman Tremaine. Walden University

PLEASE SEE CASE STUDY TRANSCRIPT BELOW

Case Study: Sherman Tremaine Program Transcript

[MUSIC PLAYING] DR. MOORE: Good afternoon. I’m Dr. Moore. Want to thank you for coming in for your appointment today. I’m going to be asking you some questions about your history and some symptoms. And to get started, I just want to ensure I have the right patient and chart. So can you tell me your name and your date of birth?

SHERMAN TREMAINE: I’m Sherman Tremaine, and Tremaine is my game game. My birthday is November 3, 1968.

DR. MOORE: Great. And can you tell me today’s date? Like the day of the week, and where we are today?

SHERMAN TREMAINE: Use any recent date, and any location is OK.

DR. MOORE: OK, Sherman. What about do you know what month this is? SHERMAN TREMAINE: It’s March 18.

DR. MOORE: And the day of the week?

SHERMAN TREMAINE: Oh, it’s a Wednesday or maybe a Thursday.

DR. MOORE: OK. And where are we today?

SHERMAN TREMAINE: I believe we’re in your office, Dr. Moore.

DR. MOORE: OK, great. So tell me a little bit about what brings you in today. What brings you here?

SHERMAN TREMAINE: Well, my sister made me come in. I was living with my mom, and she died. I was living, and not bothering anyone, and those people– those people, they just won’t leave me alone.

DR. MOORE: What people?

SHERMAN TREMAINE: The ones outside my window watching. They watch me. I can hear them, and I see their shadows. They think I don’t see them, but I do. The government sent them to watch me, so my taxes are high, so high in the sky. Do you see that bird?

DR. MOORE: Sherman, how long have you saw or heard these people? Case Study: Sherman Tremaine © 2021 Walden University, LLC 2

SHERMAN TREMAINE: Oh, for weeks, weeks and weeks and weeks. Hear that– hear that heavy metal music? They want you to think it’s weak, but it’s heavy.

DR. MOORE: No, Sherman. I don’t see any birds or hear any music. Do you sleep well, Sherman?

SHERMAN TREMAINE: I try to but the voices are loud. They keep me up for days and days. I try to watch TV, but they watch me through the screen, and they come in and poison my food. I tricked them though. I tricked them. I locked everything up in the fridge. They aren’t getting in there. Can I smoke?

DR. MOORE: No, Sherman. There is no smoking here. How much do you usually smoke?

SHERMAN TREMAINE: Well, I smoke all day, all day. Three packs a day.

DR. MOORE: Three packs a day. OK. What about alcohol? When was your last drink?

SHERMAN TREMAINE: Oh, yesterday. My sister buys me a 12-pack, and tells me to make it last until next week’s grocery run. I don’t go to the grocery store. They play too loud of the heavy metal music. They also follow me there.

DR. MOORE: What about marijuana?

SHERMAN TREMAINE: Yes, but not since my mom died three years ago.

DR. MOORE: Use any cocaine?

SHERMAN TREMAINE: No, no, no, no, no, no, no. No drugs ever, clever, ever. DR. MOORE: What about any blackouts or seizures or see or hear things from drugs or alcohol?

SHERMAN TREMAINE: No, no, never a clever [INAUDIBLE] ever.

DR. MOORE: What about any DUIs or legal issues from drugs or alcohol? SHERMAN TREMAINE: Never clever’s ever.

DR. MOORE: OK. What about any medication for your mental health? Have you tried those before, and what was your reaction to them?

SHERMAN TREMAINE: I hate Haldol and Thorazine. No, no, I’m not going to take it. Risperidone gave me boobs. No, I’m not going to take it. Seroquel, that is OK. But they’re all poison, nope, not going to take it.

DR. MOORE: OK. So tell me, any blood relatives have any mental health or substance abuse issues?

Case Study: Sherman Tremaine © 2021 Walden University, LLC 3

SHERMAN TREMAINE: They say that my dad was crazy with paranoid schizophrenia. He did in the old state hospital. They gave him his beer there. Can you believe that? Not like them today. My mom had anxiety.

DR. MOORE: Did any blood relatives commit suicide?

SHERMAN TREMAINE: Oh, no demons there. No, no.

DR. MOORE: What about you? Have you ever done anything like cut yourself, or had any thoughts about killing yourself or anyone else?

SHERMAN TREMAINE: I already told you. No demons there. Have been in the hospital three times though when I was 20.

DR. MOORE: OK. What about any medical issues? Do you have any medical problems?

SHERMAN TREMAINE: Ooh, I take metformin for diabetes. Had or I have a fatty liver, they say, but they never saw it. So I don’t know unless the aliens told them.

DR. MOORE: OK. So who raised you?

SHERMAN TREMAINE: My mom and my sister.

DR. MOORE: And who do you live with now?

SHERMAN TREMAINE: Myself, but my sister’s plotting with the government to change that. They tapped my phone.

DR. MOORE: OK. Have you ever been married? Are you single, widowed, or divorced?

SHERMAN TREMAINE: I’ve never been married.

DR. MOORE: Do you have any children? SHERMAN TREMAINE: No.

DR. MOORE: OK. What is your highest level of education?

SHERMAN TREMAINE: I went to the 10th grade.

DR. MOORE: And what do you like to do for fun?

SHERMAN TREMAINE: I don’t work, so smoking and drinking pop.

DR. MOORE: OK. Have you ever been arrested or convicted for anything legally? SHERMAN TREMAINE: No, but they have told me they would. They have told me they would if I didn’t stop calling 911 about the people outside.

DR. MOORE: OK. What about any kind of trauma as a child or an adult? Like physical, sexual, emotional abuse. Case Study: Sherman Tremaine © 2021 Walden University, LLC 4

SHERMAN TREMAINE: My dad was rough on us until he died.

DR. MOORE: OK. [MUSIC PLAYING] So thank you for answering those questions for me. Now, let’s talk about how I can best help you. [MUSIC PLAYING]

WAL_NRNP6675_05_A_EN-CC.mp4